Cory David A 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Sep 6, 2019
Insider Transaction Report
Form 4
Cory David A
DirectorPresident and CEO
Transactions
- Award
Common Stock
2019-09-05$7.95/sh+1,500$11,921→ 67,846 total
Holdings
- 29,780(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]Represents the Reporting Person's proportionate interest in securities held by Eiccose, LLC ("Eiccose"). The Reporting Person is a managing member and significant equity interest holder of Eiccose. The Reporting Person hereby disclaims any beneficial ownership of any shares directly held by Eiccose, except to the extent of its pecuniary interest therein.